拉丁裔2型糖尿病患者的肾功能下降
该回顾性研究纳入2002至2015年在Joslin糖尿病中心接受文化适应性糖尿病管理的594例西班牙裔患者,描述其长期肾脏结局。基线未控制高血压、超重和长病程T2DM与CKD风险增加相关,随访中血糖控制不佳、收缩压>140和ACEI/ARB使用与CKD发病率增加相关,而他汀使用与CKD发病率降低相关。队列年肾功能下降率估计为-1.39 ml/min/1.73 m2。
要点
- 基线未控制高血压、超重和长病程T2DM与CKD风险增加相关。
- 随访中血糖控制不佳、收缩压>140和ACEI/ARB使用与CKD发病率增加相关。
- 他汀使用与随访期间CKD发病率降低相关。
核心结论
- 拉丁裔患者肾功能下降与可改变因素如未控制糖尿病、未控制高血压和超重相关。
- 队列年肾功能下降率估计为-1.39 ml/min/1.73 m2,高于无T2DM西班牙裔及美国一般T2DM人群的既往报告,但低于该高危人群预期。
- 强调以患者为中心的文化适应性治疗对改善高危西班牙裔患者长期结局的重要性。
研究设计与样本
- 回顾性研究,纳入2002年7月至2015年7月在Joslin糖尿病中心评估的594例西班牙裔患者。
- 人口学和临床数据来自门诊访视。
主要发现
- 基线未控制高血压与CKD风险增加相关(HR 1.72;95%CI 1.18-2.51;P=0.005)。
- 基线超重与CKD风险增加相关(HR 2.68;95%CI 1.13-6.38;P=0.026)。
- 基线长病程T2DM与CKD风险增加相关(HR 1.11;95%CI 1.08-1.14;P<0.0001)。
- 随访中血糖控制不佳(HR 1.18;95%CI 1.099-1.258;P<0.0001)、收缩压>140(HR 1.01;95%CI 1.006-1.02;P=0.0002)和ACEI/ARB使用(HR 1.53;95%CI 1.03-2.29;P=0.04)与CKD发病率增加相关。
- 他汀使用与随访期间CKD发病率降低相关(HR 0.52;95%CI 0.42-0.65;P<0.0001)。
临床怎么用
- 对拉丁裔T2DM患者应重视血压、体重和血糖的综合管理以降低CKD风险。
- 他汀使用可能与CKD发病率降低相关,但需结合个体情况评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Diabetic nephropathy remains a highly prevalent microvascular complication in individuals with type 2 diabetes mellitus (T2DM). Hispanic individuals are at increased risk of metabolic and cardiovascular complications compared with non-Hispanic white individuals. We described the long-term kidney outcomes using a culturally based approach to diabetes management in Hispanic patients implemented by the Joslin Diabetes Center's Latino Diabetes Initiative. METHODS: Our retrospective study included 594 Hispanic patients evaluated at the Joslin Diabetes Center from July 2002 to July 2015. Demographic and clinical data were collected from the outpatient visits. RESULTS: Uncontrolled high blood pressure (hazard ratio [HR]: 1.72; 95% confidence interval [CI]:1.18-2.51; P = 0.005), overweight (HR: 2.68; 95% CI: 1.13-6.38; P = 0.026), and longstanding T2DM duration (HR: 1.11; 95% CI: 1.08-1.14; P < 0.0001) at baseline were significantly associated with increased risk of chronic kidney disease (CKD). Although poor glycemic control (HR: 1.18; 95% CI: 1.099-1.258; P < 0.0001), systolic blood pressure (SBP) >140 (HR: 1.01; 95% CI: 1.006-1.02; P = 0.0002), and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use (HR: 1.53; 95% CI: 1.03-2.29; P = 0.04) were significantly associated with increased CKD incidence during follow-up. Interestingly, statin use was associated with lower CKD incidence during the follow-up (HR: 0.52; 95% CI: 0.42-0.65; P < 0.0001). The annual rate of renal function decline in our cohort was estimated to be -1.39 ml/min per 1.73 m2. CONCLUSION: Renal function decline in Latinos is associated with expected but modifiable variables, such as uncontrolled diabetes, uncontrolled hypertension, and being overweight. However, the annual rate of renal function decline in our cohort was estimated to be comparatively higher than previous reports in Hispanic individuals without T2DM, and the general US population with T2DM, but lower than expected for this high-risk group. We highlight the importance of a culturally based patient-centered therapeutic approach to improve long-term outcomes in Hispanic patients at high risk of CKD.
引用
- Morales-Alvarez MC, Garcia-Dolagaray G, Millan-Fierro A, et al. Renal Function Decline in Latinos With Type 2 Diabetes. Kidney Int Rep. 2019. PMID: 31517142. doi:10.1016/j.ekir.2019.05.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。